Ginkgo Bioworks Holdings (DNA)Erste Asset Management GmbH reduced its stake -200K shares

2M

Shares reported · -200K vs prior quarter

0.14%

Disclosed portfolio weight

$16.6M

Reported value

Holdings as of

Dec 31, 2025

Filed

Feb 11, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 18, 2025Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On December 18, 2025, Ginkgo Bioworks Holdings, Inc. (the “Company”) announced that Dr. Reshma Shetty, the Company’s President, Chief Operating Officer, and member of the Board of Directors, will transition her Chief Operating Officer duties to Jennifer Wipf and Dr. Jason Kelly, the Company’s Chief Executive Officer, on January 1, 2026.”

What came next

1. Feb 26, 2026Company filing · Form 8-K · ResultsReported its results
2. Feb 26, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
3. Apr 3, 2026Company filing · Form 8-K · Acquisition or saleCompleted buying or selling a business or assets“On April 3, 2026, Ginkgo Bioworks, Inc. (the “Seller”), a wholly owned subsidiary Ginkgo Bioworks Holdings, Inc. (the “Company”) completed the previously announced transaction (the “Transaction”) with Tower Biosecurity, Inc. also known as Perimeter Systems, Inc. (the “Purchaser”) pursuant to the Stock Purchase Agreement, dated as of February 26, 2026 (the “Purchase Agreement”), by and among the Seller, the Company,…”
4. May 7, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Ginkgo Bioworks Holdings

For Ginkgo Bioworks Holdings, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DNA page.

How this filing works

• SEC Form 13F

Other disclosures at Ginkgo Bioworks Holdings

• SEC Form 4Oct 7, 2026
• SEC Form 144Oct 5, 2026
• USAspending.gov award recordAug 5, 2026
• SEC Form 13F-HRNov 12, 2025
• SEC Form 4Sep 10, 2025
• SEC Form 4Sep 10, 2025

Everything OQRO holds on this company is on its DNA page.